The actions of cannabidiol (CBD), one of the cannabis constituents, were assessed on the sleep-wakefulness cycle of male Wistar rats.
During acute experiments, single doses of 20 mg/kg CBD decreased slow-wave sleep (SWS) latency. After 40 mg/kg SWS time was significantly increased while wakefulness was decreased. REM sleep was not significantly modified. Following the once-daily injections of 40 mg/kg CBD for a period of 15 days, tolerance developed to all the above-mentioned effects.
Key wordsCannabidiol Cannabis sativa Slow-wave sleep Wakefulness
Unable to display preview. Download preview PDF.
- Karniol, I. G., Carlini, E. A.: Pharmacological interaction between cannabidiol and delta-9-tetrahydrocannabinol. Psychopharmacologia (Berl.) 33, 53–70 (1973)Google Scholar
- King, C. D.: The pharmacology of rapid eye movement sleep. Adv. Pharmacol. Chemother. 9, 1–91 (1971)Google Scholar
- Lidbrink, P.: The effect of lesions of ascending noradrenaline pathways on sleep and waking in the rat. Brain Res. 74, 19–40 (1974)Google Scholar
- Michel, F., Klein, M., Jouvet, D., Valatx, J. L.: Etude polygraphique du sommeil chez le rat. C.R. Soc. Biol. (Paris) 155, 2289–2292 (1961)Google Scholar
- Monti, J. M., Carlini, E. A.: Spontaneous behavior and sleep-wakefulness cycle in isolated and paired REM sleep deprived-marihuana treated rats. Pharmacol. Biochem. Behav. 3, 1025–1029 (1975)Google Scholar
- Moreton, J. E., Davis, W. M.: Electroencephalographic study of the effects of tetrahydrocannabinols on sleep in the rat. Neuropharmacology 12, 897–907 (1973)Google Scholar
- Steel, R. G. D., Torrie, J. H.: Principles and procedures of statistics. New York: McGraw-Hill 1960Google Scholar
- Takahashi, R. N., Karniol, I. G.: Pharmacological interaction between cannabinol and delta-9-tetrahydrocannabinol. Psychopharmacologia (Berl.) 41, 277–284 (1975)Google Scholar